BD Biosciences to Open New Facility in Florida | GenomeWeb
NEW YORK (GenomeWeb News) – Becton Dickinson’s BD Biosciences division will open a new manufacturing facility in Miami-Dade County, Florida, according to a statement today from the Beacon Council, the county’s economic development organization.
BD will invest more than $20 million in renovating the 90,000-square-feet facility, which formerly belonged to Ivax Pharmaceuticals. The Beacon Council said that the new manufacturing facility is expected to create 75 “high-paying” jobs over the next eight years.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: role for Notch signaling in congenital heart disease, sciatica risk variants, and more.

Researchers in China have used the CRISPR/Cas9 genome editing approach to alter the length of hair fibers in cashmere goats.

According to ScienceInsider, the Scripps Research Institute and the California Institute for Biomedical Research are merging.

National Cancer Institute researchers didn't report severe adverse events to Food and Drug Administration in a timely manner, the Wall Street Journal reports.